Abstract:Chinese hamster ovary (CHO) cells are the most widely used mammalian hosts for recombinant protein production. However, by conventional random integration strategy, development of a high-expressing and stable recombinant CHO cell line has always been a difficult task due to the heterogenic insertion and its caused requirement of multiple rounds of selection. Site-specific integration of transgenes into CHO hot spots is an ideal strategy to overcome these challenges since it can generate isogenic cell lines with consistent productivity and stability. In this study, we investigated three sites with potential high transcriptional activities: C12orf35, HPRT, and GRIK1, to determine the possible transcriptional hot spots in CHO cells, and further construct a reliable site-specific integration strategy to develop recombinant cell lines efficiently. Genes encoding representative proteins mCherry and anti-PD1 monoclonal antibody were targeted into these three loci respectively through CRISPR/Cas9 technology. Stable cell lines were generated successfully after a single round of selection. In comparison with a random integration control, all the targeted integration cell lines showed higher productivity, among which C12orf35 locus was the most advantageous in both productivity and cell line stability. Binding affinity and N-glycan analysis of the antibody revealed that all batches of product were of similar quality independent on integrated sites. Deep sequencing demonstrated that there was low level of off-target mutations caused by CRISPR/Cas9, but none of them contributed to the development process of transgene cell lines. Our results demonstrated the feasibility of C12orf35 as the target site for exogenous gene integration, and strongly suggested that C12orf35 targeted integration mediated by CRISPR/Cas9 is a reliable strategy for the rapid development of recombinant CHO cell lines.

Current strategies for the development of high-yield HEK293 cell lines

HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors

Affecting HEK293 Cell Growth and Production Performance by Modifying the Expression of Specific Genes

Strategies and Considerations for Improving Recombinant Antibody Production and Quality in Chinese Hamster Ovary Cells

Improvement strategies for transient gene expression in mammalian cells

Protein production from HEK293 cell line-derived stable pools with high protein quality and quantity to support discovery research

The Scattered Twelve Tribes of HEK293

Screening Strategies for High-Yield Chinese Hamster Ovary Cell Clones

Factors Affecting the Expression of Recombinant Protein and Improvement Strategies in Chinese Hamster Ovary Cells

Construction of a stable expression HEK293T engineered cell line adapted to high-density suspension culture

CHO cells in biotechnology for production of recombinant proteins: current state and further potential

Feasible development of stable HEK293 clones by CRISPR/Cas9-mediated site-specific integration for biopharmaceuticals production

Optimization of a novel expression system for recombinant protein production in CHO cells

Expression vector cassette engineering for recombinant therapeutic production in mammalian cell systems

An anti-apoptotic HEK293 cell line provides a robust and high titer platform for transient protein expression in bioreactors

Chromatin-modifying elements for recombinant protein production in mammalian cell systems

HEK-Omics: The promise of omics to optimize HEK293 for recombinant adeno-associated virus (rAAV) gene therapy manufacturing

Rapid development of stable transgene CHO cell lines by CRISPR/Cas9-mediated site-specific integration into C12orf35

Mammalian Cell Protein Expression for Biopharmaceutical Production

Comprehensive Analysis of Genomic Safe Harbors as Target Sites for Stable Expression of the Heterologous Gene in HEK293 Cells.

Strategies for efficient production of recombinant proteins in Escherichia coli: alleviating the host burden and enhancing protein activity